NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

IO Biotech, Inc. Logo
Clinical-stage biopharma developing dual-action therapeutic cancer vaccines.
United States of America
IOBT
IONIS PHARMACEUTICALS INC Logo
Biopharmaceutical firm developing RNA- and DNA-targeted therapeutics for serious diseases.
United States of America
IONS
IOVANCE BIOTHERAPEUTICS, INC. Logo
Biopharmaceutical company developing personalized TIL cell therapies for cancer.
United States of America
IOVA
Ipsen Logo
Biopharmaceutical company developing medicines for oncology, rare diseases, and neuroscience.
France
IPN
IRLAB Therapeutics Logo
Develops novel treatments for Parkinson's disease and other CNS disorders.
Sweden
IRLAB
IRONWOOD PHARMACEUTICALS INC Logo
A healthcare company developing and commercializing therapies for GI diseases.
United States of America
IRWD
ISU Abxis Co., Ltd. Logo
Develops antibody-based immunotherapies for oncology and rare diseases.
South Korea
086890
Iterum Therapeutics plc Logo
Develops and commercializes anti-infectives for multi-drug resistant pathogens.
United States of America
ITRM
Jaguar Health, Inc. Logo
Develops plant-based prescription medicines for human and animal GI diseases.
United States of America
JAGX
Janux Therapeutics, Inc. Logo
Develops tumor-activated T cell engager immunotherapies for cancer treatment.
United States of America
JANX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.